A total cholesterol of 248 mg/dL is classified as high. Standard clinical thresholds place anything at or above 240 mg/dL in the “high” category, which carries roughly double the heart disease risk compared to someone with a desirable level below 200 mg/dL.1Family Heart Foundation. Understanding Your Cholesterol Numbers That said, the number 248 on its own tells a surprisingly incomplete story, and the difference between “you should worry” and “this is manageable” depends almost entirely on what’s hiding behind that single figure.
What 248 Actually Places You On the Scale
Standard cholesterol categories in the United States work like this: below 200 mg/dL is desirable, 200 to 239 is borderline high, and 240 or above is high. At 248, you’ve crossed the threshold that guidelines flag as genuinely elevated. The Family Heart Foundation notes that reaching 240 gives you about twice the risk of heart disease compared to someone in the desirable range.1Family Heart Foundation. Understanding Your Cholesterol Numbers But “twice the risk” needs context. If your baseline risk was extremely low to begin with, doubling it may still leave you at a modest absolute risk. If you already had other risk factors stacking up, though, that doubling matters a lot more.
This is where most people get stuck. They see a number like 248, feel alarmed, and either panic or dismiss it. The honest reality is that the total cholesterol number is the least informative item on your lipid panel. Your doctor probably ordered a full panel that includes LDL cholesterol, HDL cholesterol, and triglycerides. The balance among those components is what drives the clinical conversation.
Why Total Cholesterol Is a Blunt Instrument
Total cholesterol is the sum of all the cholesterol in your blood, including the types that protect you. HDL cholesterol is the fraction that helps clear cholesterol from your arteries. If your total cholesterol is 248 but a big chunk of that is HDL, the picture is very different from someone whose 248 is almost entirely LDL.
Consider two people, both with a total cholesterol of 248. Person A has an HDL of 85 and an LDL of 130. Person B has an HDL of 35 and an LDL of 180. Person A is in decent shape; Person B has a genuinely dangerous lipid profile. The total cholesterol number is identical, but the cardiovascular risk is worlds apart. This is why cardiologists have increasingly moved toward looking at non-HDL cholesterol, which is simply your total cholesterol minus your HDL. That number captures all the particles that can contribute to plaque buildup in your arteries, including LDL but also triglyceride-rich remnants and other atherogenic particles.2PubMed Central. Non-HDL Cholesterol and Evaluation of Cardiovascular Disease Risk Both European and American cardiology guidelines now emphasize non-HDL cholesterol as an important marker beyond LDL alone.3PubMed. Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook
If your doctor hands you a lipid panel showing total cholesterol of 248, the first thing to do is look at the breakdown. An LDL below 130, an HDL above 60, and triglycerides under 150 is a very different situation than the reverse. The total number earned you the conversation, but the subfractions determine where it goes.
The Particle Count Your Standard Panel Misses
There’s a layer beneath LDL cholesterol that most routine panels don’t measure. LDL cholesterol tells you how much cholesterol is being carried in your LDL particles, but it doesn’t tell you how many particles are doing the carrying. Two people with the same LDL cholesterol level can have very different numbers of LDL particles, and research increasingly suggests the particle count matters more than the cholesterol concentration for predicting heart disease risk.
The most practical way to estimate particle count is through a blood test called apolipoprotein B, or apoB. Every atherogenic particle in your blood, whether it’s LDL, a triglyceride-rich remnant, or lipoprotein(a), carries exactly one molecule of apoB. So measuring apoB gives you a direct count of how many artery-damaging particles are circulating. A multinational expert panel concluded that apoB is superior to any cholesterol-based measure for identifying people at increased cardiovascular risk and for judging whether treatment is working.4PubMed. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel This advantage is especially pronounced in people with diabetes, metabolic syndrome, obesity, or high triglycerides, all situations where LDL cholesterol can look acceptable while particle count is dangerously high.5PubMed. Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment
If your total cholesterol is 248 and you want a clearer picture of your actual risk, asking your doctor about apoB testing is reasonable. It’s not yet part of every standard panel, but it’s widely available and increasingly recommended, especially for people whose standard numbers fall into that ambiguous middle ground.
How Your Overall Risk Is Actually Calculated
No doctor should look at your cholesterol number in isolation and make a treatment decision. The standard tool in the U.S. for estimating your ten-year risk of a heart attack or stroke is the Pooled Cohort Equations, which fold in your age, sex, race, blood pressure, whether you’re on blood pressure medication, whether you smoke, and whether you have diabetes, along with your total and HDL cholesterol.6PubMed Central. Assessment of ASCVD Risk in Primary Prevention A 35-year-old nonsmoker with normal blood pressure and a total cholesterol of 248 will get a very different risk estimate than a 60-year-old smoker with diabetes and the same cholesterol reading.
For people who land in an intermediate risk zone, where the math doesn’t clearly point toward medication or away from it, a coronary artery calcium (CAC) scan can help break the tie. This low-dose CT scan directly measures how much calcium has built up in your coronary arteries. A score of zero is powerfully reassuring regardless of your cholesterol numbers, while a high score can push a borderline decision firmly toward treatment.7PubMed Central. The Implication of Coronary Artery Calcium Testing for Cardiovascular Disease Prevention and Diabetes If you’re staring at a cholesterol of 248 and your doctor seems uncertain about whether you need a statin, a CAC scan is a reasonable next step to discuss.
When High Cholesterol Runs in the Family
Some people eat well, exercise, and still see stubbornly high cholesterol numbers. Familial hypercholesterolemia (FH) is a genetic condition that impairs the body’s ability to clear LDL from the bloodstream. It’s caused by mutations in genes that code for the LDL receptor, most commonly on chromosome 19, though mutations in the apoB gene and the PCSK9 gene can produce similar effects.8PubMed Central. Familial Hypercholesterolemia: A Literature Review of the Pathophysiology and Current and Novel Treatments Over 2,100 unique genetic variants have been linked to FH, though only a fraction have been definitively proven to cause disease through lab studies.9PubMed. Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia
FH is more common than most people realize, affecting roughly one in every 250 people. If you have a total cholesterol of 248 and a family history of early heart attacks or very high cholesterol, FH is worth screening for. Catching it matters because people with FH accumulate arterial damage from birth, and earlier, more aggressive treatment dramatically reduces their lifetime risk. For someone with FH and established cardiovascular disease, European guidelines now recommend driving LDL cholesterol below 55 mg/dL.10Family Heart Foundation. Updated Cholesterol Guidelines – What’s New? What’s Changed? That’s a far more aggressive target than what’s recommended for the general population, and it often requires combination drug therapy to achieve.
Medical Conditions That Push Cholesterol Up
Before attributing a cholesterol of 248 to diet or genetics, it’s worth ruling out secondary causes. The most common medical condition behind unexplained high cholesterol, after dietary factors, is hypothyroidism.11PubMed. Secondary causes of hyperlipidemia When the thyroid gland underperforms, the body’s ability to clear cholesterol from the blood slows down, leading to higher total cholesterol, higher LDL, and often higher triglycerides.12PubMed. Hyperlipidemia and hypothyroidism The good news is that treating the thyroid problem often brings cholesterol down substantially without any additional lipid-lowering therapy.
Other secondary causes include kidney disease, certain liver conditions, and medications like corticosteroids, some blood pressure drugs, and certain immunosuppressants. If your cholesterol jumped noticeably from a previous reading, or if it seems out of proportion to your lifestyle, a thyroid panel is a sensible addition to the workup.
How Much a Single Reading Can Fluctuate
Here’s something that rarely gets mentioned in the panic after a high reading: cholesterol levels bounce around from day to day even when nothing about your diet, medications, or health has changed. One study found that total cholesterol varies by about 5% from one day to the next, with individual variation across a year ranging from roughly 4% to 11%.13PubMed. Intra-individual variation of serum cholesterol, triglycerides and high density lipoprotein cholesterol in normal humans More than half of that variation is purely biological, not a lab error. A separate study confirmed similar day-to-day swings in total cholesterol and even larger fluctuations in triglycerides.14PubMed. Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels
What this means practically: a total cholesterol of 248 today might have been 235 last week or 258 tomorrow. If your reading is borderline or just over a threshold, a single measurement can be misleading. Repeating the test, ideally a few weeks later under similar conditions (same fasting status, same time of day), gives a more reliable picture. Doctors who jump to medication decisions based on one reading without considering this natural variability may be getting ahead of themselves.
Menopause and the Cholesterol Spike Women Don’t Expect
Many women are blindsided by a cholesterol jump in their late 40s or 50s. The menopause transition drives real, measurable changes in lipid levels that are distinct from the gradual changes caused by aging alone. Total cholesterol, LDL, and triglycerides all tend to peak during late perimenopause and early postmenopause, driven by declining estrogen levels.15PubMed Central. Lipid Changes During the Menopause Transition in Relation to Age and Weight The Study of Women’s Health Across the Nation found that early postmenopausal women had roughly twice the odds of LDL reaching 130 mg/dL or higher compared to premenopausal women.15PubMed Central. Lipid Changes During the Menopause Transition in Relation to Age and Weight
A review of lipid metabolism in women confirmed that the postmenopausal rise in total cholesterol, LDL, triglycerides, and lipoprotein(a), along with unfavorable changes in HDL, all contribute to increased cardiovascular risk during and after this transition.16Atherosclerosis. Lipid metabolism in women: A review If you’re a woman in your late 40s to mid-50s and your cholesterol just crossed 248 for the first time, the menopause transition is a likely contributor. That doesn’t mean it’s harmless and can be ignored, but it does mean that the jump may not indicate a sudden deterioration in your health or diet. It’s a predictable hormonal shift that needs monitoring and possibly treatment depending on your full risk profile.
The Role of Diet and Exercise
Lifestyle changes are the first line of treatment for most people with a total cholesterol of 248, especially if overall cardiovascular risk is moderate rather than high. The dietary lever that has the most direct impact on LDL cholesterol is saturated fat intake. When you reduce saturated fat, your liver upregulates the receptors that pull LDL particles out of the bloodstream. One study found that cutting saturated fat increased LDL receptor activity by about 10%, which corresponded to roughly a 12% drop in LDL cholesterol.17PubMed. Reducing saturated fat intake is associated with increased levels of LDL receptors on mononuclear cells in healthy men and women On the flip side, a very high saturated fat intake can suppress LDL receptor activity enough to impair your body’s ability to clear LDL particles.18PLOS ONE. Effects of a very high saturated fat diet on LDL particles in adults with atherogenic dyslipidemia: A randomized controlled trial
Exercise also helps, though its effect on LDL specifically is more modest than many people hope. A review of exercise studies confirmed that regular physical activity improves the overall lipid profile, primarily by raising HDL and lowering triglycerides, with variable effects on LDL depending on the type and intensity of exercise.19PubMed Central. Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations The biggest lifestyle wins for someone at 248 usually come from a combination: swapping saturated fats for unsaturated ones, increasing soluble fiber, losing weight if overweight, and adding regular aerobic exercise. Together these changes can bring total cholesterol down meaningfully, sometimes enough to avoid medication.
When Medication Becomes Part of the Plan
If lifestyle changes don’t bring your numbers to target, or if your overall cardiovascular risk is already elevated, statins are the mainstay of treatment. They work by blocking the enzyme in the liver responsible for producing cholesterol, which forces the liver to pull more LDL out of the bloodstream to meet its needs. Statins are among the most thoroughly studied medications in medicine, with decades of trial data showing they reduce heart attacks and strokes.
For people who can’t tolerate statins or whose cholesterol remains too high on maximum statin therapy, newer options exist. PCSK9 inhibitors are injectable drugs that dramatically lower LDL by preventing the breakdown of LDL receptors on liver cells. Ezetimibe is an oral medication that blocks cholesterol absorption in the gut. A large systematic review found that both PCSK9 inhibitors and ezetimibe likely reduce heart attacks and strokes in people at high or very high cardiovascular risk, though neither showed an impact on overall mortality.20PubMed. PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations For people at moderate or low risk, the evidence for these add-on therapies was less convincing. That distinction matters: a total cholesterol of 248 in a low-risk person may warrant a statin at most, while the same number in someone with established heart disease or FH may call for combination therapy with aggressive LDL targets.
Supplements and Over-the-Counter Options
Many people with a cholesterol reading of 248 want to try something before committing to a prescription. Red yeast rice is the supplement with the most direct pharmacological basis, since it naturally contains monacolin K, a compound chemically identical to the active ingredient in lovastatin. Combined with plant stanols and sterols, one small case series found that red yeast rice reduced total cholesterol by about 19% and LDL by about 33% over six weeks.21PubMed. Powdered red yeast rice and plant stanols and sterols to lower cholesterol Those are meaningful reductions, but the study was tiny, uncontrolled, and short-term, so the findings are preliminary at best.
The catch with red yeast rice is that because it works through the same mechanism as statins, it can carry similar side effects, including the muscle pain some people experience on prescription statins. And because supplements aren’t regulated as tightly as drugs, the amount of active compound varies wildly between brands. Some products contain almost none; others contain enough to cause side effects without the dosing precision you’d get from a prescription. Plant stanols and sterols on their own, found in fortified margarines and supplements, can lower LDL by a more modest amount. They’re generally safe but unlikely to move the needle enough on their own for someone whose cholesterol is significantly elevated.
Cholesterol in Older Adults
The relationship between cholesterol and heart disease gets muddier with age. In younger and middle-aged adults, the link between high cholesterol and cardiovascular events is well established. In older adults, the association weakens, and the evidence for aggressive treatment becomes less clear-cut.22PubMed Central. Cholesterol and cardiovascular disease in the elderly. Facts and gaps This doesn’t mean cholesterol doesn’t matter after a certain age, but the balance of benefit and risk from treatment shifts. A 45-year-old with a cholesterol of 248 stands to gain decades of reduced arterial damage from bringing the number down. An 80-year-old with the same reading may have less to gain, and the side effects of medication weigh more heavily.
There’s no clean age cutoff where treatment stops being worthwhile. The decision depends on the person’s overall health, life expectancy, functional status, and preferences. What’s clear is that applying the same urgency to a cholesterol of 248 in a healthy 40-year-old and a frail 85-year-old doesn’t make clinical sense, even though the lab value is identical.
How Guidelines Set LDL Targets
If your total cholesterol is 248, the treatment target your doctor discusses won’t be about total cholesterol at all. It will be about your LDL cholesterol. Current European guidelines stratify targets by risk level. For people at high risk, the LDL goal is below 70 mg/dL. For very high risk individuals, it’s below 55 mg/dL. For those at the highest extreme, the target drops to below 40 mg/dL.10Family Heart Foundation. Updated Cholesterol Guidelines – What’s New? What’s Changed? In patients with diabetes and mixed dyslipidemia, non-HDL cholesterol and apoB have emerged as additional targets that better capture the full atherogenic burden than LDL alone.23PubMed Central. Lipid management in type 2 diabetes and non-HDL-cholesterol: target all atherogenic lipoproteins
These targets might seem aggressive compared to the total cholesterol threshold of 240 that put you in the “high” category, and they are. The science has moved toward treating the specific harmful particles rather than managing a single composite number. A total cholesterol of 248 is the starting flag. Where the race goes from there depends on your LDL, your non-HDL, your apoB if measured, and the constellation of other risk factors that make you who you are rather than a number on a lab printout.